Literature DB >> 3005656

Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C.

D C Johnson, M R McDermott, C Chrisp, J C Glorioso.   

Abstract

Herpes simplex virus type 2 (HSV-2) mutants that were unable to express glycoprotein C (gC-2) were isolated. Deletions were made in a cloned copy of the gC-2 gene, and recombinant viruses containing these deletions were screened by using an immunoreactive plaque selection protocol. The viruses did not display a syncytial phenotype. Intravaginal inoculation of BALB/cJ mice with one of the HSV-2 gC-2- viruses produced local inflammation followed by a lethal spread of the viral infection into the nervous system in a manner identical to that produced by parental HSV-2 strain 333. Similarly, intracerebral inoculation of DBA-2 mice with the gC-2- virus produced a lethal neurological disease paralleling that caused by HSV-2 strain 333. These results indicate that gC-2 is not required for the spread of HSV-2 infections in mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005656      PMCID: PMC252873     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

2.  Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains.

Authors:  Y M Centifanto-Fitzgerald; E D Varnell; H E Kaufman
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

3.  A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1.

Authors:  S P Little; J T Jofre; R J Courtney; P A Schaffer
Journal:  Virology       Date:  1981-11       Impact factor: 3.616

4.  Expression of herpes simplex virus glycoprotein C from a DNA fragment inserted into the thymidine kinase gene of this virus.

Authors:  G T Lee; K L Pogue-Geile; L Pereira; P G Spear
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7).

Authors:  N DeLuca; D J Bzik; V C Bond; S Person; W Snipes
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

6.  Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody.

Authors:  R J Eisenberg; M Ponce de Leon; L Pereira; D Long; G H Cohen
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

7.  Anti-gD monoclonal antibodies inhibit cell fusion induced by herpes simplex virus type 1.

Authors:  A G Noble; G T Lee; R Sprague; M L Parish; P G Spear
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

8.  Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.

Authors:  N Balachandran; D Harnish; W E Rawls; S Bacchetti
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

9.  Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein.

Authors:  M F Para; L Goldstein; P G Spear
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

10.  Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C.

Authors:  R J Frink; R Eisenberg; G Cohen; E K Wagner
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more
  17 in total

1.  Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C.

Authors:  K A Kimmel; K E Dolter; G M Toth; M Levine; J C Glorioso
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C.

Authors:  C Seidel-Dugan; M Ponce de Leon; H M Friedman; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.

Authors:  Lauren M Hook; John M Lubinski; Ming Jiang; Michael K Pangburn; Harvey M Friedman
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Replication and virulence of pseudorabies virus mutants lacking glycoprotein gX.

Authors:  D R Thomsen; C C Marchioli; R J Yancey; L E Post
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

5.  Characterization of glycoprotein C-negative mutants of herpes simplex virus type 1 isolated from a patient with keratitis.

Authors:  Y Hidaka; S Sakuma; Y Kumano; H Minagawa; R Mori
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV.

Authors:  X P Liang; L A Babiuk; S van Drunen Littel-van den Hurk; D R Fitzpatrick; T J Zamb
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.

Authors:  S Laquerre; R Argnani; D B Anderson; S Zucchini; R Manservigi; J C Glorioso
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.

Authors:  H P Huemer; Y Wang; P Garred; V Koistinen; S Oppermann
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.

Authors:  H P Huemer; C Larcher; M P Dierich; D Falke
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.

Authors:  R Tal-Singer; C Peng; M Ponce De Leon; W R Abrams; B W Banfield; F Tufaro; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.